7 Best Practices for FDA and ISI Compliance in Healthcare Ads

Listen to the podcast version here:

Introduction

In healthcare and pharmaceutical marketing, compliance is more than a box to check, it’s the foundation of patient trust and brand credibility. With strict oversight from the FDA, the requirement to include Important Safety Information (ISI), and the need to uphold HIPAA privacy standards, every campaign must strike the right balance between creative impact and regulatory responsibility.

This blog explores seven best practices for ensuring FDA and ISI compliance in healthcare advertising. By following these guidelines, brands can minimize legal risk, protect patient safety, and strengthen consumer trust while still producing campaigns that resonate.

Best Practice 1: Align Claims with FDA-Approved Language

One of the most common compliance pitfalls in healthcare and pharmaceutical advertising is misaligned product claims. The FDA requires that any promotional content must be consistent with the product’s approved labeling, including indications, dosage, and limitations of use. If a statement cannot be supported by FDA-approved labeling, it should not appear in your ad.

Why This Matters

• Legal and financial risk: The FDA routinely issues warning letters and fines to companies that overstate benefits or make unsubstantiated claims.
• Patient trust: Overpromising treatment outcomes or implying off-label uses undermines credibility.

Common Compliance Pitfalls

• Using off-label claims (promoting a drug for conditions it was not approved to treat).
• Highlighting benefits without balancing risks.
• Using vague or suggestive language like “miracle cure” without FDA validation.

Best Practice in Action

Marketers should work closely with medical, legal, and regulatory (MLR) teams to ensure every claim matches FDA-approved product labeling. Creative analytics tools can also flag non-compliant phrasing early in the development process.

Best Practice 2: Ensure ISI is Clear and Accessible

Important Safety Information (ISI) is not an afterthought, it’s a legal requirement and a cornerstone of ethical healthcare advertising. The FDA mandates that ISI must be clear, conspicuous, and readily accessible wherever a product’s benefits are promoted.

Why This Matters

• Regulatory requirement: Failing to present ISI properly can result in FDA warning letters or campaign takedowns.
• Patient protection: Patients rely on ISI to understand risks, contraindications, and limitations.
• Brand credibility: Transparent communication reinforces trust.

Common Compliance Pitfalls

• Placing ISI at the bottom of the ad in small, unreadable fonts.
• Using low-contrast text that blends into background visuals.
• Making ISI scrollable without clear indicators.
• Truncating ISI on social media posts.

Best Practice in Action

• Size and contrast: Ensure ISI is legible.
• Placement: Position ISI adjacent to benefit claims.
• Mobile-first design: Test readability across devices.

Best Practice 3: Optimize ISI for Digital Formats

Digital advertising creates unique challenges for ISI presentation. From banner ads to TikTok videos, each format requires thoughtful adaptation to stay compliant.

Why This Matters

• Consumer attention spans: ISI hidden in links may go unseen.
• Regulatory scrutiny: FDA warns against ads with visible benefits but buried risks.
• Platform limitations: Character counts and layout shifts make compliance harder.

Common Compliance Pitfalls

• Abbreviating ISI in banners.
• Video ads that flash ISI too briefly.
• Social posts prioritizing slogans over disclosures.

Best Practice in Action

• Persistent ISI overlays in video ads.
• Expandable ISI modules in display ads.
• Mobile-first testing for all formats.
• Consistency across platforms.

Best Practice 4: Safeguard Patient Privacy (HIPAA Compliance)

While FDA and ISI rules focus on product claims and disclosures, HIPAA compliance ensures patient data remains protected in advertising.

Why This Matters

• Legal exposure: HIPAA violations can lead to major fines.
• Brand trust: Consumers expect healthcare brands to protect sensitive information.
• Ethics: Privacy is as important as accuracy in messaging.

Common Compliance Pitfalls

• Using real patient testimonials without consent.
• Employing sensitive targeting strategies.
• Failing to anonymize patient data in synthetic audiences.

Best Practice in Action

• Consent-first creative: Always secure permissions.
• Synthetic audiences: Replace PHI-driven targeting with anonymized models.
• Vendor vetting: Confirm platforms follow HIPAA safeguards.

Best Practice 5: Test Creatives Before Campaign Launch

Pre-campaign creative testing is a proactive way to prevent compliance errors. It ensures ad copy, visuals, and disclosures align with FDA, ISI, and HIPAA standards.

Why This Matters

• Cost savings: Fixing ads mid-campaign is expensive.
• Regulatory protection: Testing shows due diligence.
• Faster approvals: Compliance-ready drafts speed up reviews.

Common Compliance Pitfalls

• Launching ads without verifying ISI placement.
• Assuming one review applies to all campaigns.
• Overlooking platform-specific risks.
• Relying solely on manual checks.

Best Practice in Action

• Automated testing tools to scan copy and placement.
• Platform simulations to test across environments.
• Early collaboration with compliance teams.

Best Practice 6: Train Marketing Teams on Compliance Standards

Compliance is only as strong as the people behind it. Training ensures all teams understand their role in maintaining FDA, ISI, and HIPAA standards.

Why This Matters

• Knowledge alignment: Fewer errors in early drafts.
• Workflow efficiency: Reduced rounds of review.
• Risk reduction: Trained teams catch problems early.

Common Compliance Pitfalls

• Creative teams writing unbalanced claims.
• Media teams using non-compliant targeting.
• Marketers submitting incomplete ads.

Best Practice in Action

• Regular training sessions on evolving rules.
• Cross-team workshops for alignment.
• Quick-reference guides to streamline daily work.
• Compliance champions embedded in teams.

Best Practice 7: Monitor and Update Ads Continuously

Compliance isn’t static, it requires ongoing monitoring as regulations, platforms, and consumer behaviors evolve.

Why This Matters

• Evolving regulations: FDA guidance changes over time.
• Dynamic platforms: Layout changes can obscure ISI.
• Risk mitigation: Ongoing monitoring reduces exposure.

Common Compliance Pitfalls

• Treating compliance as “one and done.”
• Failing to update ISI when product labeling changes.
• Inconsistent monitoring across channels.

Best Practice in Action

• Automated monitoring tools for real-time oversight.
• Regular audits to verify ISI visibility.
• Change management workflows to update active campaigns.
• Cross-functional review of compliance dashboards.

Compliance as the Foundation of Trust

Healthcare advertising carries unique responsibilities. By aligning claims with FDA-approved language, making ISI clear, optimizing for digital formats, safeguarding privacy, testing before launch, training teams, and monitoring continuously, marketers can build campaigns that are both effective and compliant.

Compliance and creativity are not at odds. When approached together, they reinforce one another: accurate claims foster credibility, clear disclosures build trust, and privacy safeguards strengthen relationships. In regulated industries, this alignment isn’t just about avoiding fines, it’s about proving that trust is at the core of every message.

Take the Next Step with AdSkate

At AdSkate, we help brands test and analyze creatives for FDA, ISI, and HIPAA compliance. Our creative analytics tools identify risks early, streamline review processes, and give you the confidence to run campaigns that are both compliant and impactful. If you want to reduce regulatory risk while strengthening trust with your audience, book a demo today.